Novel Pharmacologic Agents for Type 2 Diabetes-Reference-Cited by-同舟云学术

Novel Pharmacologic Agents for Type 2 Diabetes

Published:2005-03 Issue:1 Volume:34 Page:155-197
ISSN:0889-8529
Container-title:Endocrinology and Metabolism Clinics of North America
language:en
Short-container-title:Endocrinology and Metabolism Clinics of North America

Author:

Uwaifo Gabriel I.,Ratner Robert E.

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference229 articles.

1. Recent developments and emerging therapies for type 2 diabetes mellitus;Evans;Drugs R D,1999

2. Novel peptides under development for the treatment of type 1 and type 2 diabetes mellitus;Baron;Curr Drug Targets Immune Endocr Metabol Disord,2002

3. Kinalski M, Sledziewski A, Telejko B, et al. Postpartum evaluation of amylin levels in gestational diabetes mellitus. American Diabetes Association, 62nd Scientific Sessions, June 2002. San Francisco, California.

4. Roles of amylin in diabetes and in regulation of nutrient load;Young;Nutrition,1998

5. Changes in amylin and amylin-like peptide concentrations and beta-cell function in response to sulfonylurea or insulin therapy in NIDDM;Rachman;Diabetes Care,1998

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hormones and Hormones Antagonists;Essentials of Pharmacodynamics and Drug Action;2024

2. Pharmacological management of diabetes;BIDE' s Diabetes Desk Book;2024

3. Transcriptional signature of islet neogenesis-associated protein peptide-treated rat pancreatic islets reveals induction of novel long non-coding RNAs;Frontiers in Endocrinology;2023-09-29

4. Carbohydrate‐based Antidiabetic Agents from Natural Products;Natural Products and their Bioactives in Antidiabetic Drug Discovery;2023-07-22

5. Diabetogenic Effects of Antihypertensive Drugs and Statins;Blood Pressure Disorders in Diabetes Mellitus;2023